Clinical Trial Update: Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lower-limb adventitial infusion of DexaMethasone via Bullfrog to reduce restenosis after ATX-based revascularization in chronic limb is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limb Ischemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Mercator MedSystems, Inc. | Conditions: Chronic Limb Ischemia | Phase 2 | Status: UNKNOWN